|
C12ORF76 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.420210E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.527200E-01 |
| Normal-vs-Stage2 |
5.823800E-02 |
| Normal-vs-Stage3 |
9.683000E-01 |
| Normal-vs-Stage4 |
1.503570E-01 |
| Stage1-vs-Stage2 |
2.353000E-01 |
| Stage1-vs-Stage3 |
3.951400E-01 |
| Stage1-vs-Stage4 |
2.499600E-01 |
| Stage2-vs-Stage3 |
8.102300E-02 |
| Stage2-vs-Stage4 |
5.458600E-01 |
| Stage3-vs-Stage4 |
1.563190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.087160E-01 |
| Normal-vs-AfricanAmerican |
3.628400E-01 |
| Normal-vs-Asian |
6.179800E-01 |
| Caucasian-vs-AfricanAmerican |
3.148400E-01 |
| Caucasian-vs-Asian |
9.742600E-01 |
| AfricanAmerican-vs-Asian |
8.025400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.613820E-01 |
| Normal-vs-Female |
1.403160E-01 |
| Male-vs-Female |
8.907200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.708600E-01 |
| Normal-vs-Extreme_Weight |
4.898000E-01 |
| Normal-vs-Obese |
2.064000E-01 |
| Normal-vs-Extreme_Obese |
8.225800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.797800E-01 |
| Normal_Weight-vs-Obese |
4.769600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.735400E-01 |
| Extreme_Weight-vs-Obese |
3.911200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.101600E-01 |
| Obese-vs-Extreme_Obese |
3.131800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.036900E-03 |
| Normal-vs-Age(41-60Yrs) |
9.208000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.832600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.327000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.054200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.287850E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.222100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.345400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.091830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.550600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.400000E-02 |
| Normal-VS-Type2 PRCC |
6.861600E-01 |
| Normal-VS-KIRP CIMP |
1.368070E-02 |
| Normal-VS-Unclassified PRCC |
1.267600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.839800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.904590E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.356000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.103600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.271600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.079800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.037800E-01 |
| Normal-vs-N1 |
8.229700E-02 |
| Normal-vs-N2 |
1.884000E-01 |
| N0-vs-N1 |
1.116610E-01 |
| N0-vs-N2 |
2.489200E-01 |
| N1-vs-N2 |
9.208200E-01 |
|
|
